Rhogam Ultra-filtered Plus Injection, Solution
Product Images NDC 0562-7805

11 FDA label images from Kedrion Biopharma Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Rhogam Ultra-filtered Plus (NDC 0562-7805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kedrion Biopharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Rhogam 01)

Figure (Rhogam 01)
An instructional black-and-white line drawing showing a hand holding and preparing to use a prefilled syringe. The illustration focuses on the correct grip for administering an injection, without showing specific product labels or text.*
FDA Label Image

Figure (Rhogam 02)

Figure (Rhogam 02)
An instructional illustration showing a hand holding a syringe, with an arrow pointing downward, indicating a step in preparing or using the syringe. No text or product details are visible in the image.*
FDA Label Image

Image (Rhogam 03)

Image (Rhogam 03)
A control form for administration of MICRhoGAM Ultra-Filtered PLUS (Rh0(D) Immune Globulin), with fields for patient and hospital information, Rh status, FMH screening, lot number, and expiration date. The form includes instructions for obstetrical service to verify patient ID, lot number, and expiration date before injection, and records details of injection timing, indications, gestational age, and attending physician.*
FDA Label Image

Image (Rhogam 04)

Image (Rhogam 04)
Control form text panel titled 'Rh0(D) Immune Globulin (Human) RhoGAM and MICRhoGAM Ultra-Filtered PLUS' used for laboratory and obstetrical service documentation. It includes sections for patient and hospital information, Rh status, testing, lot number and expiration date of the product administered, and instructions for verifying patient identification and product information before intramuscular injection. Additional fields cover injection timing, indications, gestational age, and attending physician details.*
FDA Label Image

Image (Rhogam 05)

Image (Rhogam 05)
Control form for Rho(D) Immune Globulin (Human) RhoGAM and MICRhoGAM Ultra-Filtered PLUS, including sections for patient and hospital information, Rh status, FMH screening, lot number, and technician details. Also includes instructions and checkboxes related to obstetrical service, administration date, indications, gestational age, and attending physician documentation.*
FDA Label Image

Principal Display Panel (300 μg Syringe Label)

Principal Display Panel (300 μg Syringe Label)
Label for MICRhoGAM Ultra-Filtered PLUS with a strength of 300 mcg per 1 dose. The product contains Rho(D) immune globulin (human) and is manufactured by Kedrion Biopharma Inc, Melville, NY. The label includes instructions to see directions for use and displays the NDC code 0562-7805-00.*
FDA Label Image

Principal Display Panel (300 μg Syringe Pouch Label)

Principal Display Panel (300 μg Syringe Pouch Label)
Label for MICRhoGAM Ultra-Filtered PLUS containing Rho(D) Immune Globulin (Human) 300 mcg dose. The label states it is thimerosal-free with a latex-free delivery system, prescription only. It includes storage instructions at 2°C to 8°C, the manufacturer Kedrion Biopharma Inc., and barcode with NDC 0562-7805-00. The label also notes tamper-resistant pouch sealed for safety with usage instructions.*
FDA Label Image

Principal Display Panel (300 μg Syringe Pouch Label (Rework))

Principal Display Panel (300 μg Syringe Pouch Label (Rework))
Label for MICRhoGAM Ultra-Filtered PLUS 300 ug Dose (1500 IU) of Rho(D) Immune Globulin (Human), Thimerosal-Free and Latex-Free Delivery System, by Kedrion Biopharma Inc. The label includes temperature storage instructions (2 to 8 degrees Celsius), barcode with NDC 0562-7805-00, and tamper-resistant pouch sealing instructions.*
FDA Label Image

Principal Display Panel (300 μg Syringe Pouch Carton)

Principal Display Panel (300 μg Syringe Pouch Carton)
Packaging label for MICRhoGAM Ultra-Filtered PLUS 300 mcg Dose (1500 IU), a thimerosal-free Rho(D) immune globulin (human) product. The label includes storage directions, package contents listing a prefilled syringe and related documents, active and inactive ingredient information, and the labeler Kedrion Biopharma Inc, Melville, NY.*
FDA Label Image

Principal Display Panel (300 μg Syringe Pouch Carton)

Principal Display Panel (300 μg Syringe Pouch Carton)
Packaging label for MICRhoGAM Ultra-Filtered PLUS 300 µg Dose (1500 IU) Rho(D) Immune Globulin (Human) by Kedrion Biopharma Inc. The label displays the proprietary name, active ingredient, dosage strength, storage instructions, and manufacturer information. It includes cautions for intramuscular use and warnings against intravenous use and infant injection.*
FDA Label Image

Principal Display Panel (300 μg Syringe Pouch Carton)

Principal Display Panel (300 μg Syringe Pouch Carton)
Packaging label for MICRhoGAM Ultra-Filtered PLUS 300 mcg Dose (1500 IU) Rho(D) Immune Globulin (Human) by Kedrion Biopharma Inc. The label set includes multiple panels with product name, dosing strength, Thimerosal-free indication, and storage instructions (2°C to 8°C, do not freeze). The label states: for intramuscular use only, not for infant injection, and provides storage and handling warnings. Barcode and NDC 0562-7805-25 are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.